newsfilter
← Latest News
GlobeNewswire·

Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference

  • Pulmonx Corporation (NASDAQ: LUNG) will present at the Bank of America Securities 2026 Health Care Conference in Las Vegas on Tuesday, May 12, 2026, at 8:15 AM PT / 11:15 AM ET.
  • A live & archived webcast of the presentation will be available on the "Investors" section of the Pulmonx website.
  • Pulmonx is a global leader in minimally invasive treatments for severe emphysema/COPD, including the Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, LungTraX Platform, & StratX Lung Analysis Reports.
  • The Zephyr Valve received FDA pre-market approval as a "breakthrough device" & is commercially available in more than 25 countries.
  • The Zephyr Valve is included in global treatment guidelines & is widely considered a standard of care for improving breathing, activity, & quality of life in patients with severe emphysema.
  • Brian Johnston of Gilmartin Group is the contact for investor inquiries at investors@pulmonx.com.